Investor Relations

IR Home

Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$18.70
Change (%) Stock is Up 1.05 (5.95%)
Volume1,277,004
Data as of 02/23/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
February 2018?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-4-3-2-1123
456789
02/09/18
SC 13G
Formats:  Excel HTML Adobe PDF Word
10
1112131415
02/15/18
10-K
Formats:  Excel HTML Adobe PDF Word XBRL
1617
18192021222324
25262728515253

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
02/14/18
Vanda Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results
01/30/18
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018
01/07/18
Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance
More >>
Upcoming Events
There are currently no events scheduled.
More >>
Latest Presentation
Download Documentation 2018 Corporate Presentation
Download Documentation Tradipitant Improves Worst Itch and Disease Severity in Patients with Chronic Pruritus Related to Atopic Dermatitis, 9th World Congress of Itch, October 16, 2017

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy